Login / Signup

The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges.

Jiaxi HeSong-Hui XuA James Mixson
Published in: Pharmaceutics (2020)
Histidines incorporated into carriers of nucleic acids may enhance the extracellular stability of the nanoparticle, yet aid in the intracellular disruption of the nanoparticle, enabling the release of the nucleic acid. Moreover, protonation of histidines in the endosomes may result in endosomal swelling with subsequent lysis. These properties of histidine are based on its five-member imidazole ring in which the two nitrogen atoms may form hydrogen bonds or act as a base in acidic environments. A wide variety of carriers have integrated histidines or histidine-rich domains, which include peptides, polyethylenimine, polysaccharides, platform delivery systems, viral phages, mesoporous silica particles, and liposomes. Histidine-rich carriers have played key roles in our understanding of the stability of nanocarriers and the escape of the nucleic acids from endosomes. These carriers show great promise and offer marked potential in delivering plasmids, siRNA, and mRNA to their intracellular targets.
Keyphrases
  • nucleic acid
  • drug delivery
  • escherichia coli
  • cancer therapy
  • sars cov
  • iron oxide
  • klebsiella pneumoniae
  • transition metal